Home › Trial NCT06266871
SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced Gastric Cancer
- Trial IDNCT06266871
- StatusUnknown
- PhasePhase 1/2
- Study typeInterventional
- SponsorWest China Hospital
- Enrollment64
- Start date2024-03-10
- ConditionsGastric Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.